Corrigendum to “Meta-Analysis Comparing Outcomes of Therapies for Patients with Central Sleep Apnea and Heart Failure With Reduced Ejection Fraction” (The American Journal of Cardiology (2020) 127 (73–83), (S0002914920303799), (10.1016/j.amjcard.2020.04.011))

The authors regret that the disclosure information was omitted in this article. Please find here the following disclosure information: Robin Germany is employed by Respicardia. Jeff Voigt and Sanjaya Gupta are consultants to Respicardia. Also, an error exists in table 5. The TPNS vs. GDMT treatment group should read: 38% between group change in QoL metric favoring TPNS vs. GDMT on the outcome of marked or moderate improved patient global assessment (p<0.001); data on file. The correct table is published here. The authors would like to apologise for any inconvenience caused.